Shares of NuVasive, a medical device company based in San Diego, traded down 1.94% earlier this week.
Here are four things to know:
1. Dallas-based Hodges acquired 186,425 shares of NuVasive's stock, which is valued at approximately $12,558,000 in the fourth quarter of 2016.
2. NuVasive's shares traded down 1.94 percent earlier this week, reaching $69.32.
3. The company's 12-month low is $36.81 and their 12-month high is $71.10. Its 50-day moving average price is $67.96 and its 200-day moving average price is $64.80.
4. NuVasive creates minimally disruptive surgical products and works on developing solutions for spinal ailments.
More articles on devices:
WishBone hires former Congressman Marlin Stutzman as president — 4 takeaways
Mainstay Medical's first ReActiv8 implanted in Germany — 5 observations
Medtronic plans to sell medical supplies unit, Bloomberg reports: 6 key insights